{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"16"}]}],"title":"Progression of Disease"},{"categories":[{"measurements":[{"groupId":"OG000","value":"5"}]}],"title":"Stable Disease"}],"denoms":[{"counts":[{"groupId":"OG000","value":"21"}],"units":"Participants"}],"groups":[{"description":"Patients receive arsenic trioxide IV over 1-4 hours on days 1-5 and 8-12. Treatment repeats every 28 days for a maximum of 6 courses in the absence of disease progression or unacceptable toxicity.\n\nPatients are followed every 2-3 months for 1 year and then annually thereafter.","id":"OG000","title":"Arsenic Trioxide"}],"paramType":"NUMBER","reportingStatus":"POSTED","timeFrame":"1 year","title":"Response Rate After Every 3 Courses During Treatment and Then Every 2-3 Months for 1 Year After Completion of Treatment","type":"PRIMARY","unitOfMeasure":"participants"}